Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia.

van Schaik FD, ten Kate FJ, Offerhaus GJ, Schipper ME, Vleggaar FP, van der Woude CJ, Stokkers PC, de Jong DJ, Hommes DW, van Bodegraven AA, Siersema PD, Oldenburg B; Dutch Initiative on Crohn and Colitis.

Inflamm Bowel Dis. 2011 May;17(5):1108-16. doi: 10.1002/ibd.21467. Epub 2010 Sep 7.

PMID:
20824815
[PubMed - indexed for MEDLINE]
2.

Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.

Pekow JR, Hetzel JT, Rothe JA, Hanauer SB, Turner JR, Hart J, Noffsinger A, Huo D, Rubin DT.

Inflamm Bowel Dis. 2010 Aug;16(8):1352-6. doi: 10.1002/ibd.21184.

PMID:
20027656
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.

Derikx LA, Kievit W, Drenth JP, de Jong DJ, Ponsioen CY, Oldenburg B, van der Meulen-de Jong AE, Dijkstra G, Grubben MJ, van Laarhoven CJ, Nagtegaal ID, Hoentjen F; Dutch Initiative on Crohn and Colitis.

Gastroenterology. 2014 Jan;146(1):119-28.e1. doi: 10.1053/j.gastro.2013.09.047. Epub 2013 Sep 25.

PMID:
24076060
[PubMed - indexed for MEDLINE]
4.

AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.

Dorer R, Odze RD.

Am J Surg Pathol. 2006 Jul;30(7):871-7.

PMID:
16819330
[PubMed - indexed for MEDLINE]
5.

Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.

van Schaik FD, Oldenburg B, Offerhaus GJ, Schipper ME, Vleggaar FP, Siersema PD, van Oijen MG, Ten Kate FJ.

Inflamm Bowel Dis. 2012 Mar;18(3):480-8. doi: 10.1002/ibd.21722. Epub 2011 Apr 20.

PMID:
21509910
[PubMed - indexed for MEDLINE]
6.

Colitis-associated DNA aneuploidy and dysplasia in Crohn's disease and risk of colorectal cancer.

Söderlund S, Tribukait B, Öst Å, Broström O, Karlén P, Löfberg R, Askling J, Sjöqvist U.

Inflamm Bowel Dis. 2011 May;17(5):1101-7. doi: 10.1002/ibd.21477. Epub 2010 Sep 17.

PMID:
20853434
[PubMed - indexed for MEDLINE]
7.

Dysplasia in inflammatory bowel disease.

Greenson JK.

Semin Diagn Pathol. 2002 Feb;19(1):31-7. Review.

PMID:
11936264
[PubMed - indexed for MEDLINE]
8.

Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.

Navaneethan U, Jegadeesan R, Gutierrez NG, Venkatesh PG, Hammel JP, Shen B, Kiran RP.

J Crohns Colitis. 2013 Dec 15;7(12):e684-91. doi: 10.1016/j.crohns.2013.06.006. Epub 2013 Jul 31.

PMID:
23916526
[PubMed - indexed for MEDLINE]
9.

Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota.

Jess T, Loftus EV Jr, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC, Tremaine WJ, Melton LJ 3rd, Munkholm P, Sandborn WJ.

Inflamm Bowel Dis. 2006 Aug;12(8):669-76.

PMID:
16917220
[PubMed - indexed for MEDLINE]
10.

Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom.

Thomas T, Nair P, Dronfield MW, Mayberry JF.

Eur J Gastroenterol Hepatol. 2005 Dec;17(12):1317-24.

PMID:
16292084
[PubMed - indexed for MEDLINE]
11.

The cancer "fear" in IBD patients: is it still REAL?

Connelly TM, Koltun WA.

J Gastrointest Surg. 2014 Jan;18(1):213-8. doi: 10.1007/s11605-013-2317-z. Epub 2013 Sep 4.

PMID:
24002760
[PubMed - indexed for MEDLINE]
12.

Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location.

Goldstone R, Itzkowitz S, Harpaz N, Ullman T.

Gastrointest Endosc. 2011 Nov;74(5):1087-93. doi: 10.1016/j.gie.2011.06.028. Epub 2011 Sep 10.

PMID:
21907984
[PubMed - indexed for MEDLINE]
13.

Colorectal cancer and dysplasia in inflammatory bowel disease.

Zisman TL, Rubin DT.

World J Gastroenterol. 2008 May 7;14(17):2662-9. Review.

PMID:
18461651
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

[Dysplasia in chronic inflammatory bowel diseases. On the standardized classification of the Inflammatory Bowel Disease-Dysplasia Morphology Study Group].

Otto HF.

Pathologe. 1989 Jul;10(4):240-3. German. No abstract available.

PMID:
2771893
[PubMed - indexed for MEDLINE]
15.

Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease.

Levi GS, Harpaz N.

Am J Surg Pathol. 2006 Aug;30(8):1022-9.

PMID:
16861975
[PubMed - indexed for MEDLINE]
16.

Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.

Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S.

Gastroenterology. 2003 Nov;125(5):1311-9.

PMID:
14598247
[PubMed - indexed for MEDLINE]
17.

Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.

Gui X, Liu S, Yan Y, Gao Z.

World J Gastroenterol. 2013 Jul 28;19(28):4504-10. doi: 10.3748/wjg.v19.i28.4504.

PMID:
23901225
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].

Raithel M, Weidenhiller M, Schwab D, Müller S, Hahn EG.

Z Gastroenterol. 2001 Oct;39(10):861-75. Review. German.

PMID:
11605156
[PubMed - indexed for MEDLINE]
19.

Inflammatory bowel disease as a risk factor for colorectal cancer.

Lukas M.

Dig Dis. 2010;28(4-5):619-24. doi: 10.1159/000320276. Epub 2010 Nov 18.

PMID:
21088413
[PubMed - indexed for MEDLINE]
20.

Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?

Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB.

Gastrointest Endosc. 2007 Jun;65(7):998-1004. Epub 2007 Apr 23.

PMID:
17451704
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk